Michael Alfred

Michael Alfred Portfolio

Invests via Alpine Fox Capital LLC | Managed by Michael Alfred
Invests via Alpine Fox Capital LLC
Managed by Michael Alfred
Automatically Tracked
Tracking: 0 Updated: 19 hours ago

Seasoned investor and operating executive focused on growth-stage technology and financial services businesses. Michael Alfred combines operational leadership with transaction experience across growth equity, M&A and strategic finance, often working with founder-led teams to scale revenue and margins. Prior roles span corporate strategy, buyout and portfolio company management; holds degrees in business and finance.

Seasoned investor and operating executive focused on growth-stage technology and financial services businesses. Michael Alfred combines operational leadership with transaction experience across growth equity, M&A and strategic finance, often working with founder-led teams to scale revenue and margins. Prior roles span corporate strategy, buyout and portfolio company management; holds degrees in business and finance.

Investment Philosophy & Strategy

Combines operational rigor with growth-equity discipline to back founder-led technology and financial-services companies. Prefers revenue-stage opportunities where strategic capital, M&A experience and hands-on operating support can accelerate scale and margin expansion. Allocates capital with concentrated, conviction-weighted positions and structured governance to protect downside while funding aggressive top-line investments. Maintains a 3–7 year horizon for value realization, prioritizes repeatable unit economics, customer retention, and capital-efficient growth, and emphasizes measurable KPIs, scenario-based stress testing, and collaborative governance.

Combines operational rigor with growth-equity discipline to back founder-led technology and financial-services companies. Prefers revenue-stage opportunities where strategic capital, M&A experience and hands-on operating support can accelerate scale and margin expansion. Allocates capital with concentrated, conviction-weighted positions and structured governance to protect downside while funding aggressive top-line investments. Maintains a 3–7 year horizon for value realization, prioritizes repeatable unit economics, customer retention, and capital-efficient growth, and emphasizes measurable KPIs, scenario-based stress testing, and collaborative governance.

Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
8.7%
Gain +0.03%
Monthly
0.87%
Yearly
8.7%
Drawdown
47.61%
$125.04M
Equity
Holdings
$125.04M
Investment
$119.36M
$10.49M
Profit +$43,484.15
Realized
$4.81M
Unrealized
$5.68M
Dividends
$640,781.9

Goals

Avg. 100% completed goals
Yearly
Gain > 5%
2026
100%
Yearly
Gain < 20%
2026
100%
Today
Compared To Yesterday
Gain
0.03%
Profit
$43,484.15
Win %
33%
This Week
Compared To Last Week
Gain
0.04%
Profit
$43,484.15
Win %
33%
This Month
Compared to last month
Gain
-20.7%
Profit
-$32.64M
Win %
33%
This Year
Compared to last year
Gain
17.7%
Profit
$18.8M
Win %
58%
Strive, Inc. logo
ASST Strive, Inc.
+1.8%
+$127,310.82
Bitmine Immersion Technologies, Inc. logo
BMNR Bitmine Immersion Technologies, Inc.
+1.62%
+$23,000
Canadian Pacific Kansas City Limited logo
CP Canadian Pacific Kansas City Limited
+0.86%
+$4,000
Bakkt Holdings, Inc. logo
BKKT Bakkt Holdings, Inc.
-7.76%
-$24,400
IREN Limited logo
IREN IREN Limited
-3.47%
-$908,057.81
Novo Nordisk A/S Sponsored ADR logo
NVO Novo Nordisk A/S Sponsored ADR
-2.25%
-$191,400
Constellation Brands, Inc. logo
STZ Constellation Brands, Inc.
-2.1%
-$8,550
PepsiCo, Inc. logo
PEP PepsiCo, Inc.
-1.66%
-$11,549.95
iShares Ethereum Trust logo
ETHA iShares Ethereum Trust
-1.56%
-$102,740
Opendoor Technologies Inc. logo
OPEN Opendoor Technologies Inc.
-1.53%
-$116,913.93
Cipher Mining Inc. logo
CIFR Cipher Mining Inc.
-0.9%
-$601,920
Target Corporation logo
TGT Target Corporation
-0.43%
-$1,220
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
-0.33%
-$2,250
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
36
Longs Won
13/36 36%
Profit Factor
1.7
Profitability
Shorts Won
0/0 0%
Standard Deviation
$3.62M
Average Win
$1.96M
Best Trade
(Jul 19) $18.7M
Sharpe Ratio
-11.78
Average Loss
-$653,359.2
Worst Trade
(Jul 19) -$9.99M
Z-Score
-2.25 (100%)
Commissions
$0
Avg. Trade Length
5m 1w
Expectancy
$291,481.21
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% 0.01% 0.14% 0.66% 2.24% 6.09% 14.17% 29.45% 56.14%
Consecutive Losing Trades 191 172 153 134 115 96 77 57 38 19
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV